CSIMarket
 


Biocryst Pharmaceuticals Inc   (BCRX)
Other Ticker:  
 
 

BCRX's EPS Net Growth by Quarter and Year

Biocryst Pharmaceuticals Inc 's EPS Net results by quarter and year




BCRX EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.30 -0.19 -0.03 -0.26
III Quarter September -0.19 -0.23 -330.00 -0.24
II Quarter June -0.40 -0.32 -240.00 -0.24
I Quarter March -0.28 -0.40 -0.36 -0.02
FY   -1.17 -1.14 -570.39 -0.76



BCRX EPS Net fourth quarter 2023 Y/Y Growth Comment
Biocryst Pharmaceuticals Inc in the fourth quarter 2023 recorded EPS net loss of $ -0.30 .

According to the results reported in the fourth quarter 2023, Biocryst Pharmaceuticals Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Biocryst Pharmaceuticals Inc ' s EPS Net no change of % ranks overall at the positon no. in the fourth quarter 2023.




BCRX EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Biocryst Pharmaceuticals Inc 's fourth quarter 2023 EPS Net $ -0.30 BCRX's Income Statement
Biocryst Pharmaceuticals Inc 's fourth quarter 2022 EPS Net $ -0.19 Quarterly BCRX's Income Statement
New: More BCRX's historic EPS Net Growth >>


BCRX EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biocryst Pharmaceuticals Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BCRX's IV. Quarter Q/Q EPS Net Comment
Current EPS net loss of -0.30 by Biocryst Pharmaceuticals Inc come out even worse if you take a look at EPS net loss -0.19 in the third quarter.

Within Biotechnology & Pharmaceuticals industry Biocryst Pharmaceuticals Inc achieved highest sequential EPS Net growth. While Biocryst Pharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BCRX's IV. Quarter Q/Q EPS Net Comment
Recent results of -0.30 by Biocryst Pharmaceuticals Inc look even worse if you take a look at -0.19 a quarter before.

Within Biotechnology & Pharmaceuticals industry Biocryst Pharmaceuticals Inc achieved highest sequential EPS Net growth. While Biocryst Pharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


Biocryst Pharmaceuticals Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ -1.17 $ -1.06 $ -1.10 $ -1.02 $ -1.14
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Biocryst Pharmaceuticals Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2023 period.
The situation is getting worse as the cumulative EPS net loss is inflating from $ -1.06 for the period from Sep 30 2023 to Dec 31 2022 and $ -0.98299937577743 for the twelve months ending in the quarter Dec 31 2022.

Biocryst Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Biocryst Pharmaceuticals Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2023 period.
The results are worsening as the cumulative EPS net loss is inflating from $ -1.06 in the twelve months ending a quarter before and $ -0.98299937577743 for the twelve months ending in the quarter a year ago.

Biocryst Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
BCRX's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for BCRX's Competitors
EPS Net Growth for Biocryst Pharmaceuticals Inc 's Suppliers
EPS Net Growth for BCRX's Customers

You may also want to know
BCRX's Annual Growth Rates BCRX's Profitability Ratios BCRX's Asset Turnover Ratio BCRX's Dividend Growth
BCRX's Roe BCRX's Valuation Ratios BCRX's Financial Strength Ratios BCRX's Dividend Payout Ratio
BCRX's Roa BCRX's Inventory Turnover Ratio BCRX's Growth Rates BCRX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Alpha Pro Tech Ltd 102.01%$ 102.011 
Stryker Corp101.49%$ 101.490 
Cytek Biosciences Inc 101.19%$ 101.187 
Corcept Therapeutics Inc93.66%$ 93.655 
Quest Diagnostics Inc91.92%$ 91.923 
Intuitive Surgical Inc 84.06%$ 84.063 
Astrazeneca Plc80.57%$ 80.569 
Cadre Holdings Inc 77.21%$ 77.209 
Dr Reddy s Laboratories Limited76.47%$ 76.471 
3m Company73.79%$ 73.795 
Electromed Inc 72.73%$ 72.727 
Select Medical Holdings Corp65.75%$ 65.751 
United Therapeutics Corporation63.06%$ 63.056 
Neurocrine Biosciences Inc 61.33%$ 61.332 
Halozyme Therapeutics Inc 55.17%$ 55.172 
Abbott Laboratories54.67%$ 54.667 
Lemaitre Vascular Inc 48.89%$ 48.895 
Msa Safety Incorporated45.39%$ 45.386 
Docgo Inc 45.08%$ 45.083 
Catalyst Pharmaceuticals Inc 41.53%$ 41.526 
Integer Holdings Corporation41.39%$ 41.393 
Healthcare Services Group Inc 40.63%$ 40.631 
Chemed Corporation40.08%$ 40.076 
Ufp Technologies Inc 37.57%$ 37.565 
Hologic Inc37.33%$ 37.333 
Baxter International Inc 34.83%$ 34.825 
West Pharmaceutical Services Inc 34.80%$ 34.797 
National Research Corporation34.48%$ 34.481 
Semler Scientific Inc 33.61%$ 33.610 
Viemed Healthcare Inc 32.99%$ 32.987 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com